Dr. Neeraj Agarwal joins Tom and Brian for an in-depth look at important data from TALAPRO-2, which demonstrated significant improvement in OS for patients with mCRPC through the use of talazoparib with enzalutamide.
Dr. Neeraj Agarwal joins Tom and Brian for an in-depth look at important data from TALAPRO-2, which demonstrated significant improvement in OS for patients with mCRPC through the use of talazoparib with enzalutamide.